Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 39,700Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 247TEVA PHARM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9066957

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9415008

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9066957

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9066957

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9066957

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9415008

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9066957

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9066957

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code : U-645

Delist Requested :

Patent Use Description : TREATMENT OF ASTHMA

Patent Expiration Date : 2034-10-06

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 9731087

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-18

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 8714149

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-02-25

blank